Highlights from ISPOR Europe 2024

Highlights from ISPOR Europe 2024

Experience the best moments of ISPOR 2024. From impactful discussions to showcasing our innovative solutions like EVIGATOR, ANCHOR and OncoCase, see how GIPAM is shaping the future of market access and real-world evidence.

News & Webinars

Implications of PICO Scoping in the European JCA for Health Technology Developers

Why the US FDA’s Growing Focus on Real-World Evidence Should Matter to You

Why is GIPAM Global?

Reflections and Key Insights from ISPOR Europe 2024

GIPAM GmbH and Inka Health announce their partnership to Advance HEOR and Regulatory Science through Enhanced Real-World Evidence and Analytics

How EVIGATOR Empowers Pharmaceutical Companies to Navigate Complex Evidence Generation

GIPAM Welcomes New Leadership to Enhance Strategic Vision and Drive Growth

Enhance Your Research with Real World Evidence Training

Official Hearing on New Medical Research Act: Deutscher Bundestag

Our Managing Director, Professor Thomas Wilke, recently attended the official hearing by the ‘Deutscher Bundestag’ concerning their new medical research act. Read his thoughts on the significant changes proposed by this legislation.

See all ❯

Highlights from ISPOR Europe 2024

News & Webinars

Do you have questions?